Malignancy Flashcards

1
Q

what is the best way to identify mature non-lymphoid cells?

A

morphology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

malignant haemopoiesis is characterised by what?

A

inc numbers of abnorml and dysfunctional cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what malignancy is characterised by proliferation of abnormal proegnitors with block in differentiation/maturation?

A

acute luekaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what malignancy is characterised by proliferation of abnormal progentiors but NO block in differentiation/maturation?

A

chronic myeloproliferative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is meant by ‘clone’ with regards to driver mutations?

A

population of cells dervied from one ‘parent cell’- the daughter cells share genetic marker of parent (they can diversify but will always share genetic backbone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

normal haemopoeisis is poly/monoclonal?

A

normal- polyclonal

malignant- usually monoclonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the two types of haematological malignancy?

A

lineage (myeloid or lymphoid)

anatomical site (blood/lymph)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

blood involvement is which kind of malignancy?

A

blood involvment = leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

lymph node involvemnt is which kind of malignancy?

A

lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which malignancy involved the marrow?

A

myeloma → plasma cell malignancy in marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which malignancy can involve blood and lymph nodes?

A

Chronic Lymphocytic Leukaemia (CLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

if somone presents with lymph nodes what should you always check?

A

bloods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

define acute leukaemia

A

excess of ‘blasts’ >20% in either the peripheral blood or bone marrow → decrease of normal haemopoetic reserve i.e. low platelts, low neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

who is acute myeloid leukaemia most common in?

A

more common in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is AML investigated?

A

blood count

coag screen

bone marrow aspirate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

auer rods are typically seen in which malignancy?

A

Acute Myeloid Leukaemia (AML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how is AML treated?

A

intensive chemo for multiple cycles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

during chemo for AML risk of infection increases. if neutropenic fever suspected what should be done?

A

cover with broad spectrum antibiotic particulary gram -ve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what acute leukaemia tends to occur mainly in children?

A

acute lymphoblastic leukaemia ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ALL is a disease of which cells?

A

disease of primitive lymphoid cells (lymphoblasts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ALL has a tendancy to involve which body system?

A

CNS

(in males can get into testes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

why is bone pain common in ALL?

A

rapid marrow expansion causes pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how is ALL treated?

A

chemotherapy followed by maintainence therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are the problems of marrow suppression?

A

anaemia

neutropenia

thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
which gram stain is higher risk in neutropenic patients?
gram -ve higher risk (can cause life threatening spesis within hours)
26
which responds better to treatment- low or high grade Non-hodgkins lymphoma?
high grade (grows more rapidly but repsonds better to treatment than slow growing low grade tumours)
27
how is a diagnosis of Non-Hodgkins Lymphoma confirmed?
biopsy
28
what protein is found on Hodgkins lymphoma?
CD30
29
what is the treatment for Hodgkins?
brentuximab vedotin
30
who tends to get hodgkins and who gets NHL?
young- Hodgkins older- Non-Hodgkins
31
which is more common Hodgkins or Non-Hodgkins?
Non-Hodgkins
32
what is the abnormal cell found in Hodgkins Lymphoma?
Reed-sternberg cells (abnormal type of B lymphocytes)
33
which has a better prognosis, hodgkins or non-hodgkins?
Hodgkins- generally easier to treat
34
what is a malignancy of plasma cells?
myeloma
35
what are the direct tumour cell effects of myeloma on the body?
bone lesions bone pain inc in calcium marrwo failure
36
what are the paraprotein mediated effects of myeloma on the body?
renal failure immune suppression amyloid
37
how is myeloma classified?
type of antibody produced
38
what is the benign form of myeloma?
MGUS (premalignant) (monoclonal gammopathy of unknown significance)
39
which steps in the cell cycle are involved in differentiation and in proliferation?
differentiate- G0 and G1 proliferate- S, G2, M
40
what the two types of treatments for tumours with regards to the cell cycle?
cell cycle specific (tumour specific) non-cell cycle specific (non-tumour specific)
41
duration of dose rather than dose more important in specific or non-specific treamtent?
specific In non-secific cumalitive dose more importnant rather than duration
42
tyrosine kinase inhibitors can be used in the treatment of which malignancy?
chronic myeloid leukamia
43
give an example of a tyrosine kinase inhibitor
imatinib
44
in what disease is philadelphia chromosome seen?
Chronic myeloid leukaemia
45
what are the two subtypes of Chronic Myeloproliferative DIsorders?
BRC-ABL1 positive BRC-ABL1 negative
46
what is seen in CML?
proliferation if myeloid cells- granulocytes
47
other than myeloproliferative disorders what else can cause a high Hb?
chronic hypoxia i.e. COPD/sleep apnoea is a common reason for eleavted Hb
48
bloods can look identical in myeloproliferative disorders vs reactive but what differentiates the two?
eoisinophilia and basophilia in MPD reactive will have an explanation i.e. empyema
49
what can be used to treat CML?
tyrosine kinase inhibitors i.e. imatinib
50
what are the three forms of BRC-ABL1 negative myeloproliferative disorders?
Polycythameia Rubra Vera Idiopathic myelofibrosis essential Thrombocytopenia
51
what are the two forms of Polycythaemia Rubra Vera?
primary or secondary
52
what are some signs of polycythaemia?
headache, fatigue itchy- especially when in bath/shower plethroic (redness)
53
what mutation is seen in \>95% of people with Polycythaemia?
JKA2 mutation
54
what is the treamtent for polycythaemia rubra vera?
venesect to Hc\<0.45 aspirin cytotoxic oral chemo i.e. hydroxycarbamide
55
what is essential thrombocytopenia?
uncontrolled production of abnormal platelets?
56
what does essential thrombocytopenia result in?
thrombosis at very high levels can cause bleeding \>1500 (platelts can bind to VWF so circulatory levels decrease)
57
why is platelet count following surgery less realible in diagnosing throbocytopenia?
inc in platelets following surgery is normal- way of dealign with massive haemostatic challenge
58
the JAK 2 gene is found in 50% patients with essential thrombovytopenia. in those that dont what other gene mutation will be present?
CALR- calreticulin MPL mutation also
59
how is essential thrombocytopenia treated?
aspirin cytoreductive therapy to control proliferation i.e. hydroxycarbamide
60
tear drop shaped RBC's can be seen in which mhyeloproliferatve disorder?
myelofibrosis
61
in additon to tear drop RBC's what else is seen on blood film in myelofibrosis?
leucoerythroblastic | (nucelated red cells and myelocytes)
62
how is myelofibrosis treated?
supportive: blood transfusion, platelets allogenic stem cell transplantation in select few JAK2 inhibitors